News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
229,451 Results
Type
Article (7198)
Company Profile (16)
Press Release (222237)
Multimedia
Podcasts (3)
Webinars (1)
Section
Business (63150)
Career Advice (295)
Deals (14769)
Drug Delivery (28)
Drug Development (36812)
Employer Resources (24)
FDA (6423)
Job Trends (4910)
News (121856)
Policy (11644)
Tag
Academia (569)
Accelerated approval (2)
Adcomms (7)
Allergies (38)
Alliances (14793)
ALS (32)
Alzheimer's disease (607)
Antibody-drug conjugate (ADC) (47)
Approvals (6474)
Artificial intelligence (112)
Autoimmune disease (10)
Automation (4)
Bankruptcy (147)
Best Places to Work (4609)
BIOSECURE Act (2)
Biosimilars (21)
Biotechnology (18)
Bladder cancer (60)
Brain cancer (15)
Breast cancer (119)
Cancer (1241)
Cardiovascular disease (75)
Career advice (260)
Career pathing (4)
CAR-T (101)
Cell therapy (239)
Cervical cancer (13)
Clinical research (31359)
Collaboration (321)
Compensation (96)
Complete response letters (7)
COVID-19 (734)
CRISPR (19)
C-suite (82)
Cystic fibrosis (39)
Data (1469)
Denatured (1)
Depression (21)
Diabetes (114)
Diagnostics (2245)
Digital health (5)
Diversity (2)
Diversity, equity & inclusion (9)
Drug discovery (48)
Drug pricing (44)
Drug shortages (17)
Duchenne muscular dystrophy (46)
Earnings (33874)
Editorial (15)
Employer branding (1)
Employer resources (19)
Events (31310)
Executive appointments (257)
FDA (7238)
Friedreich's ataxia (2)
Frontotemporal dementia (6)
Funding (281)
Gene editing (48)
Generative AI (11)
Gene therapy (145)
GLP-1 (189)
Government (1258)
Grass and pollen (2)
Guidances (136)
Healthcare (6143)
Huntington's disease (5)
IgA nephropathy (16)
Immunology and inflammation (44)
Indications (18)
Infectious disease (797)
Inflammatory bowel disease (67)
Inflation Reduction Act (5)
Influenza (25)
Intellectual property (57)
Interviews (46)
IPO (8050)
IRA (17)
Job creations (571)
Job search strategy (221)
Kidney cancer (8)
Labor market (5)
Layoffs (41)
Leadership (4)
Legal (2101)
Liver cancer (41)
Lung cancer (170)
Lymphoma (90)
Machine learning (3)
Management (7)
Manufacturing (111)
MASH (47)
Medical device (4596)
Medtech (4597)
Mergers & acquisitions (7110)
Metabolic disorders (297)
Multiple sclerosis (45)
NASH (8)
Neurodegenerative disease (31)
Neuropsychiatric disorders (5)
Neuroscience (845)
NextGen: Class of 2025 (1500)
Non-profit (712)
Obesity (142)
Opinion (78)
Ovarian cancer (59)
Pain (42)
Pancreatic cancer (53)
Parkinson's disease (73)
Partnered (6)
Patents (150)
Patient recruitment (73)
Peanut (17)
People (14583)
Pharmaceutical (8)
Pharmacy benefit managers (7)
Phase I (10023)
Phase II (13812)
Phase III (10331)
Pipeline (980)
Policy (34)
Postmarket research (797)
Preclinical (3686)
Press Release (9)
Prostate cancer (53)
Psychedelics (11)
Radiopharmaceuticals (119)
Rare diseases (163)
Real estate (1005)
Recruiting (7)
Regulatory (9215)
Reports (16)
Research institute (510)
Resumes & cover letters (39)
Rett syndrome (6)
RNA editing (3)
RSV (16)
Schizophrenia (31)
Series A (45)
Series B (35)
Service/supplier (2)
Sickle cell disease (23)
Special edition (2)
Spinal muscular atrophy (31)
Sponsored (14)
Startups (677)
Stomach cancer (5)
Supply chain (26)
Tariffs (5)
The Weekly (1)
Vaccines (175)
Venture capitalists (5)
Weight loss (76)
Women's health (6)
Worklife (4)
Date
Today (89)
Last 7 days (512)
Last 30 days (1810)
Last 365 days (15681)
2025 (6079)
2024 (16925)
2023 (19105)
2022 (22251)
2021 (23645)
2020 (21806)
2019 (14441)
2018 (10641)
2017 (11458)
2016 (9546)
2015 (11737)
2014 (8106)
2013 (5880)
2012 (6043)
2011 (6753)
2010 (6216)
Location
Africa (176)
Alabama (17)
Alaska (2)
Arizona (56)
Arkansas (3)
Asia (17618)
Australia (4871)
California (3220)
Canada (1194)
China (260)
Colorado (134)
Connecticut (176)
Delaware (67)
Europe (28163)
Florida (479)
Georgia (75)
Idaho (6)
Illinois (225)
India (20)
Indiana (129)
Japan (101)
Kansas (15)
Kentucky (6)
Louisiana (5)
Maine (37)
Maryland (382)
Massachusetts (2276)
Michigan (56)
Minnesota (112)
Missouri (37)
Montana (11)
Nebraska (8)
Nevada (48)
New Hampshire (36)
New Jersey (1091)
New Mexico (3)
New York (1006)
North Carolina (422)
North Dakota (2)
Northern California (1442)
Ohio (69)
Oklahoma (1)
Oregon (7)
Pennsylvania (733)
Puerto Rico (8)
Rhode Island (8)
South America (302)
South Carolina (16)
Southern California (1235)
Tennessee (48)
Texas (493)
United States (11722)
Utah (76)
Virginia (87)
Washington D.C. (19)
Washington State (363)
West Virginia (2)
Wisconsin (13)
229,451 Results for "mesoblast limited".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Mesoblast Appoints Corporate Finance Leader Lyn Cobley To Board
April 29, 2025
·
6 min read
Press Releases
Mesoblast Extends Payer Coverage For Ryoncil® to Over 100 Million US Lives
April 17, 2025
·
5 min read
Press Releases
Mesoblast Financial Results and Corporate Update Webcast
February 26, 2025
·
2 min read
Press Releases
Dr. Gregory George MD PhD Joins Mesoblast Board
February 24, 2025
·
6 min read
Pharm Country
Mesoblast Corporate Presentation at Investor Conference - June 03, 2024
Mesoblast Limited, Chief Executive Silviu Itescu provided a corporate update at the Bell Potter Emerging Leaders Conference.
June 2, 2024
·
5 min read
Press Releases
Mesoblast CEO to Deliver Featured Presentation at ISCT North America Virtual Town Hall
March 12, 2025
·
5 min read
Press Releases
Mesoblast Files Request for Type B Meeting with FDA to Discuss Accelerated Approval Pathway for Revascor® in Ischemic Heart Failure
April 3, 2025
·
5 min read
Press Releases
Mesoblast’s RYONCIL® is the First U.S. FDA-Approved Mesenchymal Stromal Cell (MSC) Therapy
December 18, 2024
·
10 min read
Policy
Mesoblast to File Biologics License Application for Ryoncil® FDA Approval Next Week
Mesoblast Limited, global leader in allogeneic cellular medicines for inflammatory diseases, confirmed that it will file its Biologics License Application for approval of Ryoncil® in the treatment of children with steroid-refractory acute graft versus host disease with the U.S. Food and Drug Administration next week.
July 1, 2024
·
4 min read
Press Releases
Mesoblast to be Added to Nasdaq Biotechnology Index
December 19, 2024
·
5 min read
1 of 22,946
Next
